Literature DB >> 10879572

Methicillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost?

B D Cookson1.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of nosocomial infections worldwide. Interpretation of community MRSA trends is problematical, in that the term is ill-defined, and related data are difficult to put into context. There are four relevant battlefronts, all of interest to risk assessment and prevention. These comprise the following: the issues relating to an increasing pool of patients with MRSA discharged from hospitals into the community; MRSA spreading to patients in nursing and residential homes; and MRSA spreading from patients and healthcare workers to others in the community. There are often difficulties in determining whether the fourth issue, MRSA arising apparently de novo in the community, is in fact due to one of these other fronts. All these battlefronts are important and not yet lost. However, we must agree on definitions and design-appropriate surveillance strategies, so that we can best inform prevention and control activities to contain these emerged or emerging problems.

Entities:  

Mesh:

Year:  2000        PMID: 10879572     DOI: 10.1086/501781

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  15 in total

1.  Methicillin-resistant Staphylococcus aureus in First Nations communities in Canada.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-11       Impact factor: 2.253

2.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-11       Impact factor: 2.253

3.  Staphylococcus aureus carriage among participants at the 13th European Congress of Clinical Microbiology and Infectious Diseases.

Authors:  E Nulens; I Gould; F MacKenzie; A Deplano; B Cookson; E Alp; E Bouza; A Voss
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

4.  Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia.

Authors:  F G O'Brien; T T Lim; F N Chong; G W Coombs; M C Enright; D A Robinson; A Monk; B Saïd-Salim; B N Kreiswirth; W B Grubb
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  Community-acquired methicillin-resistant Staphylococcus aureus, Finland.

Authors:  Saara Salmenlinna; Outi Lyytikäinen; Jaana Vuopio-Varkila
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

6.  Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia.

Authors:  Geoffrey W Coombs; Graeme R Nimmo; Jan M Bell; Flavia Huygens; Frances G O'Brien; Mary J Malkowski; Julie C Pearson; Alex J Stephens; Philip M Giffard
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

7.  Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial.

Authors:  Lona Mody; Carol A Kauffman; Shelly A McNeil; Andrzej T Galecki; Suzanne F Bradley
Journal:  Clin Infect Dis       Date:  2003-11-06       Impact factor: 9.079

8.  Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate.

Authors:  Wipawadee Sianglum; Potjanee Srimanote; Wijit Wonglumsom; Kanokwan Kittiniyom; Supayang P Voravuthikunchai
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

9.  Staphylococcus aureus bacteremia, Australia.

Authors:  Peter Collignon; Graeme R Nimmo; Thomas Gottlieb; Iain B Gosbell
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883

10.  Antibiotic resistance patterns of bacterial isolates from blood in San Francisco County, California, 1996-1999.

Authors:  Susan S Huang; Brian J Labus; Michael C Samuel; Dairian T Wan; Arthur L Reingold
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.